Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04826276 · ClinicalTrials.gov registry record · NA
Effects of Smoking State on Decision Making
A NA study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT04826276: Completed NA study, sponsored by Wake Forest University Health Sciences.
NCT04826276 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 5 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04826276, a NA study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
Adult smokers will be tested using behavioral and neuroimaging measures after smoking as usual and after overnight abstinence.
Primary Outcome
number of high effort selections
Interventions
- OTHER smoking abstinence
- OTHER smoking satiety
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2022-09-01 |
| Est. Completion | 2023-03-28 |
| Phase | NA |
What the finished NCT04826276 record still lists
NCT04826276 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which smoking abstinence is the first listed.
NCT04826276 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04826276 about?
NCT04826276 is a clinical study titled "Effects of Smoking State on Decision Making". Adult smokers will be tested using behavioral and neuroimaging measures after smoking as usual and after overnight abstinence.
What is the current status of trial NCT04826276?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2022-09-01. Estimated completion is 2023-03-28.
What interventions are being tested in trial NCT04826276?
The interventions under investigation include: smoking abstinence (OTHER), smoking satiety (OTHER).
Who is sponsoring clinical trial NCT04826276?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04826276's enrollment target sits among peer trials
5 1988th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI